Daniel Schiwek

demonstrates the value of Gyrolab® in HCP analysis and bioprocess

Daniel Schiwek.jpgDaniel Schiwek, Project Evaluation Manager at Global Biological Operations, Lonza AG, Visp, Switzerland, presented ‘Biopharmaceutical manufacturing in microbial systems – Gyrolab as an analytical platform supporting process development' at Gyrolab Seminar in Siena, Italy.

Gyrolab workstation was compared with ELISA for HCP analysis and delivered:

  • Faster assay development times
  • Reduced consumption of reagents and samples
  • Reduced matrix effects (lower sample dilution)
  • Increased dynamic range

View Seminar

You can find out more about this work in the poster by Peiris and Schiwek : Download